Kruger T F, Haque D, Acosta A A, Pleban P, Swanson R J, Simmons K F, Matta J F, Morshedi M, Oehninger S
Jones Institute for Reproductive Medicine, Eastern Virginia Medical School, Norfolk 23507.
Arch Androl. 1988;20(3):237-41. doi: 10.3109/01485018808987078.
Acrosin, a neutral proteinase, is located within the acrosome. The aim of this study was to evaluate acrosin concentrations in patients with severe damage of the sperm head and to determine whether acrosin concentration could predict the chances of fertilization in an IVF program. Sixty patients were accepted into this study, prospectively. The patients were divided into two groups, those with a normal morphology of less than 14% (group I, n = 33) and those with normal morphology less than 14% (group II, n = 27). All patients had a sperm concentration of less than 20 million sperm/ml and less than 30% progressively motile sperm. The acrosin assays were performed on the semen sample obtained on the day of IVF. Routine IVF insemination procedures were used, and only mature oocytes were considered. The only factor that showed a significant correlation of fertilization was normal morphology (p less that 0.01). The mean acrosin level was 73.4 /+- 38.6 mED/10 million sperm in group I and 70.9 /+- 42.7 mIU/10 million sperm in group II (no significant difference). The fertilization rate in group I was 45.4% and in group II, 77.7% p less than 0.002). Acrosin levels were not significantly different in patients with and without fertilization (72.0 /+- 42.1 and 73.6 /+- mIU/10 million sperm, respectively).
顶体蛋白酶是一种中性蛋白酶,位于顶体内。本研究的目的是评估精子头部严重受损患者的顶体蛋白酶浓度,并确定顶体蛋白酶浓度是否能够预测体外受精(IVF)程序中的受精几率。本研究前瞻性地纳入了60例患者。这些患者被分为两组,精子形态正常率低于14%的患者(第一组,n = 33)和精子形态正常率低于14%的患者(第二组,n = 27)。所有患者的精子浓度均低于2000万精子/ml,且进行性运动精子比例低于30%。在IVF当天采集的精液样本上进行顶体蛋白酶检测。采用常规IVF授精程序,仅考虑成熟卵母细胞。唯一与受精呈显著相关的因素是正常形态(p < 0.01)。第一组的平均顶体蛋白酶水平为73.4±38.6 mED/1000万精子,第二组为70.9±42.7 mIU/1000万精子(无显著差异)。第一组的受精率为45.4%,第二组为77.7%(p < 0.002)。受精患者和未受精患者的顶体蛋白酶水平无显著差异(分别为72.0±42.1和73.6±mIU/1000万精子)。